212 related articles for article (PubMed ID: 1623124)
1. Peptide models for the membrane destabilizing actions of viral fusion proteins.
Epand RM; Cheetham JJ; Epand RF; Yeagle PL; Richardson CD; Rockwell A; Degrado WF
Biopolymers; 1992 Apr; 32(4):309-14. PubMed ID: 1623124
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the infectivity of influenza virus and the ability of its fusion peptide to perturb bilayers.
Epand RM; Epand RF
Biochem Biophys Res Commun; 1994 Aug; 202(3):1420-5. PubMed ID: 8060322
[TBL] [Abstract][Full Text] [Related]
3. Conformational sampling of influenza fusion peptide in membrane bilayers as a function of termini and protonation states.
Panahi A; Feig M
J Phys Chem B; 2010 Jan; 114(3):1407-16. PubMed ID: 20043654
[TBL] [Abstract][Full Text] [Related]
4. Membrane orientation of the SIV fusion peptide determines its effect on bilayer stability and ability to promote membrane fusion.
Epand RF; Martin I; Ruysschaert JM; Epand RM
Biochem Biophys Res Commun; 1994 Dec; 205(3):1938-43. PubMed ID: 7811285
[TBL] [Abstract][Full Text] [Related]
5. The Role of histidine residues in low-pH-mediated viral membrane fusion.
Kampmann T; Mueller DS; Mark AE; Young PR; Kobe B
Structure; 2006 Oct; 14(10):1481-7. PubMed ID: 17027497
[TBL] [Abstract][Full Text] [Related]
6. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
[TBL] [Abstract][Full Text] [Related]
7. Single mutation effects on conformational change and membrane deformation of influenza hemagglutinin fusion peptides.
Li J; Das P; Zhou R
J Phys Chem B; 2010 Jul; 114(26):8799-806. PubMed ID: 20552971
[TBL] [Abstract][Full Text] [Related]
8. Factors contributing to the fusogenic potency of foamy virus.
Epand RM; Epand RF
Biochem Biophys Res Commun; 2001 Jun; 284(4):870-4. PubMed ID: 11409874
[TBL] [Abstract][Full Text] [Related]
9. Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function.
Langley WA; Thoennes S; Bradley KC; Galloway SE; Talekar GR; Cummings SF; Varecková E; Russell RJ; Steinhauer DA
Virology; 2009 Nov; 394(2):321-30. PubMed ID: 19755201
[TBL] [Abstract][Full Text] [Related]
10. Fusion peptides and transmembrane domains of fusion proteins are characterized by different but specific structural properties.
Weise K; Reed J
Chembiochem; 2008 Apr; 9(6):934-43. PubMed ID: 18330852
[TBL] [Abstract][Full Text] [Related]
11. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
Lev N; Shai Y
J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
[TBL] [Abstract][Full Text] [Related]
12. Interaction between dengue virus fusion peptide and lipid bilayers depends on peptide clustering.
Stauffer F; Melo MN; Carneiro FA; Sousa FJ; Juliano MA; Juliano L; Mohana-Borges R; Da Poian AT; Castanho MA
Mol Membr Biol; 2008 Feb; 25(2):128-38. PubMed ID: 18307100
[TBL] [Abstract][Full Text] [Related]
13. The membrane topology of the fusion peptide region of influenza hemagglutinin determined by spin-labeling EPR.
Macosko JC; Kim CH; Shin YK
J Mol Biol; 1997 Apr; 267(5):1139-48. PubMed ID: 9150402
[TBL] [Abstract][Full Text] [Related]
14. The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: putative role during viral entry.
Sainz B; Rausch JM; Gallaher WR; Garry RF; Wimley WC
Biochemistry; 2005 Jan; 44(3):947-58. PubMed ID: 15654751
[TBL] [Abstract][Full Text] [Related]
15. The identification and characterization of fusogenic domains in herpes virus glycoprotein B molecules.
Galdiero S; Vitiello M; D'Isanto M; Falanga A; Cantisani M; Browne H; Pedone C; Galdiero M
Chembiochem; 2008 Mar; 9(5):758-67. PubMed ID: 18311743
[TBL] [Abstract][Full Text] [Related]
16. Autocatalytic activation of influenza hemagglutinin.
Lee JH; Goulian M; Boder ET
J Mol Biol; 2006 Dec; 364(3):275-82. PubMed ID: 17011576
[TBL] [Abstract][Full Text] [Related]
17. The structural biology of type I viral membrane fusion.
Colman PM; Lawrence MC
Nat Rev Mol Cell Biol; 2003 Apr; 4(4):309-19. PubMed ID: 12671653
[TBL] [Abstract][Full Text] [Related]
18. Interaction of fusogenic synthetic peptide with phospholipid bilayers: orientation of the peptide alpha-helix and binding isotherm.
Ishiguro R; Matsumoto M; Takahashi S
Biochemistry; 1996 Apr; 35(15):4976-83. PubMed ID: 8664290
[TBL] [Abstract][Full Text] [Related]
19. Role of lipids in the permeabilization of membranes by class L amphipathic helical peptides.
Polozov IV; Polozova AI; Tytler EM; Anantharamaiah GM; Segrest JP; Woolley GA; Epand RM
Biochemistry; 1997 Jul; 36(30):9237-45. PubMed ID: 9230057
[TBL] [Abstract][Full Text] [Related]
20. A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus.
Ghosh JK; Ovadia M; Shai Y
Biochemistry; 1997 Dec; 36(49):15451-62. PubMed ID: 9398274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
